Journal
PLoS Neglected Tropical Diseases
Publication Date
2-1-2022
Volume
16
Issue
2
First Page
e0010096
Document Type
Open Access Publication
DOI
10.1371/journal.pntd.0010096
Rights and Permissions
Tavul L, Laman M, Howard C, Kotty B, Samuel A, et al. (2022) Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial. PLOS Neglected Tropical Diseases 16(2): e0010096. https://doi.org/10.1371/journal.pntd.0010096. © 2022 Tavul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Tavul, Livingstone; O'Brian, Kobie; Weil, Gary J.; Goss, Charles W.; and et al, "Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial." PLoS Neglected Tropical Diseases. 16, 2. e0010096 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11453
Table S1
Table S2.pdf (81 kB)
Table S2
Table S3.pdf (135 kB)
Table S3
Table S4.pdf (95 kB)
Table S4
Table S5.pdf (113 kB)
Table S5
Table S6.pdf (137 kB)
Table S6
Figure S1.pdf (146 kB)
Figure S1
